Randy examines how patient support hubs and field reimbursement managers can work together to support provider offices throughout the patient access journey. He highlights connected workflows, hybrid field and virtual support, and broader performance measures as ways to coordinate access services and direct expertise where it is needed.
To learn more about Inizio Engage's approach to patient access, view the webinar Beyond Program Metrics: Using Connected Data to Prove the Value of Patient Services.
Read on for Randy's insights.
Your Hub May Be Working. Your Provider Still May Be Drowning.
By Randy Quist, Vice President, Field Reimbursement, Inizio Engage
Yet even when these components are performing as designed, one critical stakeholder may still be struggling: the provider's office.
In Inizio Engage’s Patient Access Hub Services: Feedback and Satisfaction Survey, Wave 1, conducted in February 2026 among 40 life sciences manufacturer Patient Services stakeholders, only 58% reported being highly satisfied with their current Hub provider. Respondents identified opportunities including complex case management, disruption of communication, technology and interoperability, and actionable reporting.
It raises an important question: Is a patient support program simply processing access activities efficiently, or is it making access easier for the people responsible for getting patients onto therapy?
The Provider Office Is Where Complexity Converges
Provider offices sit at the intersection of prior authorizations, payer requirements, specialty pharmacy processes, enrollment, affordability, appeals, documentation and patient follow-up, often across multiple therapies and manufacturers.
A Hub can successfully complete its portion of a process while the provider still experiences significant friction. The problem is not necessarily the performance of any single service. It is often the space between services.
When hub teams, FRMs, specialty pharmacies, provider offices and other stakeholders operate through disconnected workflows, the provider can become the de facto coordinator of the patient’s access journey.
That is a role the industry should work to eliminate.
Stop Thinking About the Hub and FRM as Separate Services
The Hub may have visibility into patient-level barriers, while an FRM understands reimbursement challenges occurring across an account or territory. Viewed independently, each provides valuable support. Connected effectively, those insights can reveal something more useful.
A recurring documentation issue may signal an opportunity for provider education. A pattern of authorization denials may require targeted reimbursement support. Repeated escalations could indicate a workflow problem that a virtual or field-based FRM can help resolve.
Instead of waiting for the provider to identify the problem and determine whom to contact, an integrated model can recognize patterns and direct the appropriate expertise to the issue.
The goal should not be more touches. It should be fewer unnecessary touches and better intervention when it matters.
That distinction can produce measurable results. Across applicable Inizio Engage Patient Solutions programs, Hub teams achieve up to 96% first-call resolution. In another Inizio Engage access-support program, redesigning a fragmented patient/PBM workflow increased real-time resolution from 29% to 90%.
The lesson is bigger than either metric: eliminating unnecessary handoffs can be as important as optimizing the individual services involved.
The Right Resource Does Not Always Need to Be in the Field
Some accounts require intensive, in-person reimbursement support. Others may need periodic education, rapid virtual assistance, or intervention only when a complex access barrier emerges.
A hybrid model combining field and virtual FRMs allows manufacturers to align resources with actual account needs rather than geography alone.
That can be particularly important in rare and ultra rare disease, where patients and experienced treatment centers may be geographically dispersed.
The question becomes less about how many FRMs should we deploy? and more about where, when and how should expertise be deployed to remove access barriers?
Measure the Friction You Remove
Traditional operational measures remain important. Speed, resolution, enrollment, abandonment and time to therapy all provide valuable information.
But manufacturers should also examine whether their access and reimbursement education supports the reduction in administrative burden that provider offices must endure.
Are issues resolved without repeated follow-up? Are Hub and field teams sharing information effectively? Are recurring barriers identified across accounts? Are providers repeatedly supplying information that already exists elsewhere? Do escalations reach the right expertise quickly?
These questions shift performance measurement from individual service components toward the experience created by the entire access model.
Patients do not experience a Hub, FRM, specialty pharmacy and provider office as separate organizational functions. They experience one journey to therapy.
Providers should not have to navigate those boundaries either.
The next evolution of patient access will not come simply from adding another technology, channel or service. It will come from connecting existing capabilities more intelligently and deploying human expertise where it creates the greatest value.
Because a Hub can hit every operational target and still leave a provider chasing answers.
And when the provider is still carrying the burden of connecting the access journey, the system isn’t working as well as the metrics may suggest.
Inizio Engage connects the provider, Hub, FRM, specialty pharmacy cohesively to enable a proactive patient experience, view this webinar to learn more: Beyond Program Metrics: Using Connected Data to Prove the Value of Patient Services.
Sponsored guest posts are bylined articles that are screened by Drug Channels to ensure a topical relevance to our exclusive audience. The content of Sponsored Posts does not necessarily reflect the views of HMP Omnimedia, LLC, Drug Channels Institute, its parent company, or any of its employees. To find out how you can publish a guest post on Drug Channels, please contact Marie Caldwell (mcaldwell@hmpglobal.com).